Pyridostigmine Bromide Tablet
Product Images NDC 65841-819

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 65841-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (4f18b45a D2c9 49d8 Ad9e 245c8011615d 01)

Figure (4f18b45a D2c9 49d8 Ad9e 245c8011615d 01)
Chemical structure of pyridostigmine bromide, showing a pyridinium ring with a methoxycarbonyl dimethylamine side group and associated bromide ion.*
FDA Label Image

Figure (4f18b45a D2c9 49d8 Ad9e 245c8011615d 02)

Figure (4f18b45a D2c9 49d8 Ad9e 245c8011615d 02)
Label for Pyridostigmine Bromide Tablets USP, 60 mg, oral tablets manufactured by Zydus Lifesciences Limited. The package contains 100 tablets identified by NDC 65841-819-01. It includes a caution about moisture sensitivity and desiccant removal, storage instructions, and a child-resistant packaging notice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.